DE69007486D1 - Verwendung von calciumantagonisten für die behandlung von narben. - Google Patents
Verwendung von calciumantagonisten für die behandlung von narben.Info
- Publication number
- DE69007486D1 DE69007486D1 DE90912115T DE69007486T DE69007486D1 DE 69007486 D1 DE69007486 D1 DE 69007486D1 DE 90912115 T DE90912115 T DE 90912115T DE 69007486 T DE69007486 T DE 69007486T DE 69007486 D1 DE69007486 D1 DE 69007486D1
- Authority
- DE
- Germany
- Prior art keywords
- scars
- treatment
- calcium antagonists
- antagonists
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38760489A | 1989-07-31 | 1989-07-31 | |
PCT/US1990/004294 WO1991001624A2 (en) | 1989-07-31 | 1990-07-31 | Use of calcium antagonists for treating scars |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69007486D1 true DE69007486D1 (de) | 1994-04-21 |
DE69007486T2 DE69007486T2 (de) | 1994-08-11 |
Family
ID=23530617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69007486T Expired - Lifetime DE69007486T2 (de) | 1989-07-31 | 1990-07-31 | Verwendung von calciumantagonisten für die behandlung von narben. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0485470B1 (de) |
JP (1) | JP3149180B2 (de) |
CA (1) | CA2059558C (de) |
DE (1) | DE69007486T2 (de) |
WO (1) | WO1991001624A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5569678A (en) * | 1989-07-31 | 1996-10-29 | Massachusetts Institute Of Technology | Control of wound scar production |
EP0651637B1 (de) * | 1992-07-20 | 2006-10-04 | Massachusetts Institute Of Technology | Kontrolle der wundvernarbung mit calmodulin-inhibitoren oder protein-kinase-c-inhibitoren |
US5552162A (en) * | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
US5750141A (en) * | 1993-04-08 | 1998-05-12 | The University Of Queensland | Administration of vaso-active agent and therapeutic agent |
FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
US6031005A (en) * | 1998-08-03 | 2000-02-29 | Easterling; W. Jerry | Composition and method for treating Peyronie's disease and related connective tissue disorders |
US6525100B1 (en) | 1998-08-03 | 2003-02-25 | W. Jerry Easterling | Composition and method for treating peyronie's disease and related fibrotic tissue disorders |
US6627663B2 (en) | 1998-08-03 | 2003-09-30 | W. Jerry Easterling | Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method |
JP3157784B2 (ja) | 1998-08-19 | 2001-04-16 | 新潟日本電気株式会社 | 電子写真感光体およびその製造方法 |
US7094431B2 (en) * | 2000-10-12 | 2006-08-22 | Mickey L. Peshoff | Method of healing skin wounds in mammals and a composition therefor |
ES2304610T3 (es) * | 2003-06-09 | 2008-10-16 | Ascend Therapeutics, Inc. | Tratamiento y prevencion de cicatrizacion excesiva con 4-hidroxi-tamoxifeno. |
GB201119089D0 (en) * | 2011-11-04 | 2011-12-21 | Isis Innovation | Treatment of musculoskeletal fibroproliferative disorders |
-
1990
- 1990-07-31 DE DE69007486T patent/DE69007486T2/de not_active Expired - Lifetime
- 1990-07-31 JP JP51163690A patent/JP3149180B2/ja not_active Expired - Fee Related
- 1990-07-31 WO PCT/US1990/004294 patent/WO1991001624A2/en active Search and Examination
- 1990-07-31 CA CA002059558A patent/CA2059558C/en not_active Expired - Lifetime
- 1990-07-31 EP EP90912115A patent/EP0485470B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2059558A1 (en) | 1991-02-01 |
JP3149180B2 (ja) | 2001-03-26 |
DE69007486T2 (de) | 1994-08-11 |
WO1991001624A8 (en) | 2005-06-16 |
CA2059558C (en) | 2002-11-12 |
EP0485470A1 (de) | 1992-05-20 |
JPH05500045A (ja) | 1993-01-14 |
EP0485470B1 (de) | 1994-03-16 |
WO1991001624A2 (en) | 1991-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59608738D1 (de) | Verwendung von epinastin für die behandlung von schmerzen | |
DE68913667D1 (de) | Imidazole für die Behandlung von Atherosclerose. | |
ATE235906T1 (de) | Substituierte phenylpyrimidine derivate, für die behandlung oder prevention von zns-erkrankungen | |
DE3789053D1 (de) | Vorrichtung zur Behandlung von Hypertrophie der Vorsteherdrüse. | |
DE3779346D1 (de) | Zusammensetzung zur behandlung der haut. | |
DE69718731D1 (de) | Kombinationstherapie für die Behandlung von Psychosen | |
DE69022249D1 (de) | Knochenwachsapplikator zur Behandlung von Knochengewebe. | |
DE3584013D1 (de) | Zubereitung zur behandlung von psoriasis. | |
DE69008820D1 (de) | Verfahren zur Behandlung von Polymerisaten. | |
DE69019488D1 (de) | Behandlung von Geflügel. | |
DE3578611D1 (de) | Instrumente zur behandlung von verformten naegeln bei menschlichen patienten. | |
DE3685633D1 (de) | Behandlung von knochenstoerungen. | |
DE69018043D1 (de) | Behandlung von Geflügel. | |
DE69019345D1 (de) | Zusammensetzung zur behandlung von samen. | |
DE69003009D1 (de) | Verfahren zur Behandlung von Fasermaterialien. | |
DE69007486D1 (de) | Verwendung von calciumantagonisten für die behandlung von narben. | |
DE69007989D1 (de) | Verwendung von Sorbentmittel für die Polyolefinreinigung. | |
DE3889416D1 (de) | Wärmebeständiges Schmiermittel zur Behandlung von Kunstfasern. | |
DE3789079D1 (de) | Zusammensetzung für die Behandlung von Fasern. | |
ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
DE58906239D1 (de) | Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn. | |
DE3856329D1 (de) | Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie | |
DE59005545D1 (de) | Verwendung von hydroxymischethern als hilfsmittel für die feststoffentwässerung. | |
DE69007374D1 (de) | Injektionssystem für die Behandlung von Zellen. | |
DE69101847D1 (de) | Zubereitung für die Verhütung oder die Behandlung von Hypertriglyceridämie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |